Neural Noise

Synaptrix Labs non-invasive BCI platform

2 min read

  • Synaptrix Labs is developing a non-invasive BCI platform based on wearable EEG. 1
  • Mark Cuban has backed Synaptrix Labs. 1
  • The platform is positioned to explore whether AI can level the playing field for wearable EEG. 1 1

Weekly enrichment (2026-07-20)

  • Synaptrix Labs (founded 2023, New York City) was co-founded by CEO Aryan Govil, who spent about five years at NYU Langone’s clinical research lab, and CTO Eric Yao, whose background is in time-series forecasting and quantitative modeling.2
  • Mark Cuban led a seed round in October 2025; the amount was undisclosed but industry experts estimated $8–10 million, bringing total funding to roughly $10.5M after a ~$500K 2024 pre-seed led by Underdog Labs.2
  • Flagship product Neuralis is a wearable EEG headset that uses dry sensors and on-device AI signal processing to decode brain signals and translate them into wheelchair navigation commands.2
  • Decoding is powered by NeuroDiffusion, a deep-learning platform that filters EEG noise artifacts to isolate cortical intent from scalp recordings, reflecting the company’s “deep learning first, not better sensors” thesis.23
  • Synaptrix signed a licensing agreement with EEG hardware maker IDUN Technologies to embed NeuroDiffusion’s artifact-removal AI directly in their sensors.2
  • An early feasibility clinical trial (EMPOWER, NCT06169696), sponsored by Synaptrix Labs in collaboration with Columbia University, evaluates non-invasive wheelchair control with an estimated 6 participants.4
  • Trial documentation describes the Neuralis headset with dry sensors over the occipital lobe/visual cortex, Bluetooth streaming to a mobile app, and cloud/edge computing—differing from marketing that emphasizes motor-cortex decoding (a discrepancy worth flagging).4
  • In March 2026 Synaptrix unveiled Atlas, a further non-invasive BCI demonstrated driving a wheelchair by thought, positioning the company alongside non-invasive players such as Neurable, Cognixion, and NextMind (acquired by Snap).3
  • The company reported seven full-time employees and a new Manhattan office as it prepared for the Columbia trial and explored additional licensing.2

Footnotes

  1. https://neurotechnology.substack.com/p/synaptrix-cuban ↩ ↩2 ↩3 ↩4

  2. https://www.citybiz.co/article/764275/synaptrix-labs-gets-seed-funding-from-mark-cuban-to-advance-brain-computer-interface/ ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  3. https://insidebci.com/news/2026-03-12-synaptrix-labs-unveils-atlas-non-invasive-bci-driving-a-wheelchair-with-thought-alone/ ↩ ↩2

  4. https://clinicaltrials.gov/study/NCT06169696 ↩ ↩2

Graph View